Bowang Pharmaceutical
About:
Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
Website: https://www.argobiopharma.com
Top Investors: GSR United Capital, Huagai Capital, Loyal Valley Capital, Tao Capital, SDIC Fund Management
Description:
Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
Total Funding Amount:
700M CNY
Headquarters Location:
Jiading, Shanghai, China
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-11-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai